Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-04-21 Utter Christine Marie SVP, FINANCE & CAO Sale 10b5-1 −4,321 $55.05 $238K 38,059
2023-04-21 Utter Christine Marie SVP, FINANCE & CAO Option exercise 10b5-1 +371 $33.02 $12K 38,430
2023-04-21 Utter Christine Marie SVP, FINANCE & CAO Sale 10b5-1 −351 $55.09 $19K 38,079
2023-04-21 Utter Christine Marie SVP, FINANCE & CAO Sale 10b5-1 −20 $55.64 $1K 38,059
2023-04-21 Utter Christine Marie SVP, FINANCE & CAO Option exercise · Stock Option (Right to Buy) 10b5-1 −4,321 $33.02 $143K 0
2023-04-21 Utter Christine Marie SVP, FINANCE & CAO Option exercise · Stock Option (Right to Buy) 10b5-1 −371 $33.02 $12K 0
2023-04-21 Reeve Emma Director Sale 10b5-1 −4,228 $55.04 $233K 7,300
2023-04-21 Reeve Emma Director Sale 10b5-1 −100 $55.57 $6K 7,200
2023-04-18 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −732 $52.04 $38K 64,805
2023-04-18 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +26,000 103,856
2023-04-18 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −1,211 $52.04 $63K 102,645
2023-04-18 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) 10b5-1 +65,000 65,000
2023-04-17 SOUTHWELL DAVID P Director Option exercise 10b5-1 +11,429 $18.01 $206K 21,929
2023-04-17 SOUTHWELL DAVID P Director Sale 10b5-1 −6,241 $50.69 $316K 15,688
2023-04-17 SOUTHWELL DAVID P Director Sale 10b5-1 −5,188 $51.43 $267K 10,500
2023-04-17 SOUTHWELL DAVID P Director Option exercise · Stock Option (Right to Buy) 10b5-1 −11,429 $18.01 $206K 0
2023-04-17 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +3,292 $30.86 $102K 78,670
2023-04-17 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −3,292 $51.42 $169K 75,378
2023-04-17 Boulding Mark Elliott EXEC. VP AND CLO Option exercise 10b5-1 +58,631 $30.86 $1.8M 134,009
2023-04-17 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −58,631 $51.42 $3.0M 75,378

Page 39 of 41 · 804 trades